Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Internship and Residency | 43 | 2024 | 5880 | 2.270 |
Why?
|
Internal Medicine | 28 | 2021 | 1051 | 2.040 |
Why?
|
Humanities | 6 | 2023 | 55 | 1.780 |
Why?
|
Personnel Staffing and Scheduling | 11 | 2022 | 495 | 1.240 |
Why?
|
Education, Medical | 6 | 2022 | 1725 | 0.950 |
Why?
|
Curriculum | 13 | 2024 | 3743 | 0.910 |
Why?
|
Workload | 9 | 2022 | 844 | 0.840 |
Why?
|
Education, Medical, Graduate | 8 | 2024 | 2373 | 0.750 |
Why?
|
Patient Care | 3 | 2018 | 622 | 0.740 |
Why?
|
Plagiarism | 2 | 2010 | 22 | 0.730 |
Why?
|
Empathy | 3 | 2023 | 473 | 0.730 |
Why?
|
Work Schedule Tolerance | 9 | 2022 | 551 | 0.710 |
Why?
|
Professional Competence | 2 | 2014 | 431 | 0.600 |
Why?
|
Burnout, Professional | 5 | 2021 | 704 | 0.550 |
Why?
|
Art | 2 | 2014 | 64 | 0.540 |
Why?
|
Physical Examination | 5 | 2014 | 1255 | 0.520 |
Why?
|
Leadership | 2 | 2015 | 1385 | 0.510 |
Why?
|
Clinical Competence | 9 | 2024 | 4792 | 0.510 |
Why?
|
Physician-Patient Relations | 6 | 2024 | 3249 | 0.500 |
Why?
|
Physician Executives | 1 | 2015 | 134 | 0.480 |
Why?
|
School Admission Criteria | 2 | 2015 | 107 | 0.450 |
Why?
|
Teaching | 4 | 2021 | 1170 | 0.440 |
Why?
|
Inservice Training | 1 | 2015 | 375 | 0.410 |
Why?
|
Ethics, Professional | 2 | 2010 | 100 | 0.400 |
Why?
|
Education, Medical, Undergraduate | 3 | 2023 | 1070 | 0.390 |
Why?
|
Program Evaluation | 4 | 2015 | 2495 | 0.390 |
Why?
|
Attitude of Health Personnel | 5 | 2018 | 3889 | 0.390 |
Why?
|
Paintings | 2 | 2014 | 103 | 0.380 |
Why?
|
Observation | 2 | 2013 | 310 | 0.370 |
Why?
|
Students, Medical | 4 | 2024 | 1936 | 0.370 |
Why?
|
Publishing | 2 | 2018 | 833 | 0.360 |
Why?
|
Aspergillosis | 3 | 2008 | 242 | 0.340 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2008 | 24 | 0.310 |
Why?
|
Antifungal Agents | 3 | 2008 | 752 | 0.300 |
Why?
|
Physicians | 3 | 2018 | 4591 | 0.290 |
Why?
|
Diagnosis | 1 | 2008 | 157 | 0.290 |
Why?
|
Health Personnel | 1 | 2021 | 3335 | 0.290 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5336 | 0.280 |
Why?
|
Candidiasis | 1 | 2008 | 365 | 0.250 |
Why?
|
Career Choice | 2 | 2018 | 756 | 0.230 |
Why?
|
Museums | 2 | 2014 | 20 | 0.230 |
Why?
|
Feedback | 1 | 2007 | 791 | 0.220 |
Why?
|
Medically Underserved Area | 1 | 2006 | 254 | 0.220 |
Why?
|
Safety Management | 1 | 2009 | 760 | 0.210 |
Why?
|
Medical Staff, Hospital | 4 | 2018 | 601 | 0.210 |
Why?
|
Medical Records | 1 | 2007 | 1408 | 0.200 |
Why?
|
Humans | 85 | 2024 | 761504 | 0.200 |
Why?
|
Pneumonia, Pneumocystis | 3 | 2014 | 242 | 0.190 |
Why?
|
Social Responsibility | 1 | 2004 | 386 | 0.190 |
Why?
|
Emigration and Immigration | 1 | 2004 | 397 | 0.190 |
Why?
|
Life Style | 1 | 2013 | 3917 | 0.190 |
Why?
|
Training Support | 2 | 2018 | 109 | 0.180 |
Why?
|
Documentation | 1 | 2007 | 897 | 0.180 |
Why?
|
Policy | 1 | 2024 | 508 | 0.170 |
Why?
|
Physician's Role | 2 | 2012 | 917 | 0.170 |
Why?
|
Foreign Medical Graduates | 2 | 2010 | 77 | 0.170 |
Why?
|
Radiology | 1 | 2013 | 2113 | 0.170 |
Why?
|
Communication | 5 | 2024 | 3873 | 0.150 |
Why?
|
Earthquakes | 1 | 2021 | 191 | 0.150 |
Why?
|
Wakefulness | 3 | 2021 | 1265 | 0.150 |
Why?
|
Organizational Innovation | 1 | 2021 | 537 | 0.150 |
Why?
|
Legionnaires' Disease | 1 | 2018 | 49 | 0.150 |
Why?
|
Legionella pneumophila | 1 | 2018 | 49 | 0.150 |
Why?
|
Interdisciplinary Communication | 2 | 2014 | 931 | 0.150 |
Why?
|
Hospital Administrators | 1 | 2018 | 57 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 239 | 0.150 |
Why?
|
Schools, Medical | 1 | 2023 | 879 | 0.140 |
Why?
|
Hemoptysis | 1 | 2018 | 152 | 0.140 |
Why?
|
Ethics, Medical | 1 | 2012 | 783 | 0.140 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2759 | 0.130 |
Why?
|
Efficiency, Organizational | 3 | 2017 | 695 | 0.130 |
Why?
|
Pneumocystis carinii | 2 | 2014 | 72 | 0.120 |
Why?
|
Quality Improvement | 3 | 2024 | 3801 | 0.120 |
Why?
|
Hospitals, Teaching | 3 | 2010 | 1156 | 0.120 |
Why?
|
Primaquine | 1 | 2014 | 28 | 0.120 |
Why?
|
Diagnosis, Differential | 14 | 2018 | 12974 | 0.120 |
Why?
|
Haemophilus Infections | 1 | 1995 | 94 | 0.120 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2014 | 662 | 0.120 |
Why?
|
Fever | 4 | 2015 | 1618 | 0.120 |
Why?
|
Teaching Rounds | 2 | 2017 | 275 | 0.120 |
Why?
|
Hematology | 1 | 2018 | 243 | 0.120 |
Why?
|
Haemophilus influenzae | 1 | 1995 | 178 | 0.120 |
Why?
|
Sleep Deprivation | 3 | 2019 | 846 | 0.120 |
Why?
|
Boston | 8 | 2019 | 9326 | 0.120 |
Why?
|
Bundle-Branch Block | 2 | 2013 | 276 | 0.120 |
Why?
|
Immunocompromised Host | 4 | 2011 | 856 | 0.120 |
Why?
|
Drama | 1 | 2014 | 15 | 0.120 |
Why?
|
United States | 18 | 2023 | 72334 | 0.110 |
Why?
|
Poverty | 1 | 2006 | 2698 | 0.110 |
Why?
|
Emergency Medicine | 1 | 2002 | 1198 | 0.110 |
Why?
|
Faculty, Medical | 2 | 2018 | 1203 | 0.110 |
Why?
|
Students | 1 | 2023 | 1741 | 0.110 |
Why?
|
Career Mobility | 1 | 2015 | 259 | 0.110 |
Why?
|
Chagas Cardiomyopathy | 1 | 2013 | 71 | 0.110 |
Why?
|
Organizational Culture | 1 | 2016 | 508 | 0.110 |
Why?
|
Tachycardia, Ventricular | 2 | 2013 | 1304 | 0.110 |
Why?
|
Hantavirus Pulmonary Syndrome | 1 | 2012 | 11 | 0.100 |
Why?
|
Computers, Handheld | 1 | 2014 | 210 | 0.100 |
Why?
|
Plasmodium vivax | 1 | 2014 | 202 | 0.100 |
Why?
|
Patient Care Team | 2 | 2017 | 2521 | 0.100 |
Why?
|
Malaria, Vivax | 1 | 2014 | 166 | 0.100 |
Why?
|
Group Processes | 1 | 2014 | 228 | 0.100 |
Why?
|
Ebolavirus | 1 | 2015 | 251 | 0.100 |
Why?
|
Physicians, Women | 1 | 2018 | 508 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1367 | 0.100 |
Why?
|
Histoplasma | 1 | 2011 | 39 | 0.100 |
Why?
|
Plasmodium | 1 | 2014 | 246 | 0.100 |
Why?
|
Sarcoma, Kaposi | 1 | 1995 | 374 | 0.100 |
Why?
|
Developing Countries | 1 | 2004 | 2885 | 0.100 |
Why?
|
Histoplasmosis | 1 | 2011 | 63 | 0.100 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2012 | 93 | 0.090 |
Why?
|
Trypanosoma cruzi | 1 | 2013 | 206 | 0.090 |
Why?
|
Job Satisfaction | 2 | 2018 | 544 | 0.090 |
Why?
|
Dermatology | 1 | 2021 | 918 | 0.090 |
Why?
|
Fluid Therapy | 1 | 2015 | 579 | 0.090 |
Why?
|
Writing | 2 | 2015 | 199 | 0.090 |
Why?
|
Thinking | 1 | 2014 | 320 | 0.090 |
Why?
|
Syncope | 1 | 2013 | 427 | 0.090 |
Why?
|
Prions | 1 | 2012 | 180 | 0.090 |
Why?
|
Commerce | 1 | 2015 | 606 | 0.090 |
Why?
|
Triazoles | 2 | 2007 | 903 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3882 | 0.090 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 420 | 0.080 |
Why?
|
Female | 32 | 2023 | 392644 | 0.080 |
Why?
|
Genital Diseases, Female | 1 | 2010 | 192 | 0.080 |
Why?
|
Lipopeptides | 1 | 2009 | 71 | 0.080 |
Why?
|
Paracentesis | 1 | 2009 | 98 | 0.080 |
Why?
|
Adrenal Glands | 1 | 2011 | 552 | 0.080 |
Why?
|
Mastocytosis, Systemic | 1 | 2010 | 103 | 0.080 |
Why?
|
Research Personnel | 1 | 2013 | 588 | 0.080 |
Why?
|
Osteogenesis Imperfecta | 1 | 2009 | 81 | 0.080 |
Why?
|
Foot Diseases | 1 | 2010 | 147 | 0.080 |
Why?
|
Hospital Costs | 2 | 2012 | 947 | 0.080 |
Why?
|
Medical Errors | 3 | 2006 | 1263 | 0.080 |
Why?
|
Hospital Mortality | 3 | 2019 | 5294 | 0.080 |
Why?
|
Eosinophilia | 2 | 2010 | 560 | 0.080 |
Why?
|
Time and Motion Studies | 2 | 2018 | 143 | 0.080 |
Why?
|
Prevalence | 4 | 2023 | 15732 | 0.080 |
Why?
|
von Willebrand Diseases | 1 | 2009 | 132 | 0.070 |
Why?
|
Bacteremia | 1 | 1995 | 979 | 0.070 |
Why?
|
Oxazoles | 1 | 2009 | 199 | 0.070 |
Why?
|
Hypopituitarism | 1 | 2010 | 250 | 0.070 |
Why?
|
Uveitis | 1 | 2011 | 395 | 0.070 |
Why?
|
Antimalarials | 1 | 2014 | 907 | 0.070 |
Why?
|
Endometrium | 1 | 2010 | 403 | 0.070 |
Why?
|
Gastroenteritis | 1 | 2009 | 236 | 0.070 |
Why?
|
Male | 33 | 2021 | 360804 | 0.070 |
Why?
|
Program Development | 1 | 2014 | 1297 | 0.070 |
Why?
|
Factor VIII | 1 | 2009 | 348 | 0.070 |
Why?
|
Fatal Outcome | 4 | 2012 | 1834 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 4016 | 0.070 |
Why?
|
Social Justice | 2 | 2018 | 478 | 0.070 |
Why?
|
Dermatomycoses | 1 | 2007 | 48 | 0.070 |
Why?
|
Patient Care Management | 1 | 2010 | 302 | 0.070 |
Why?
|
Antigens, CD1 | 1 | 2009 | 439 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1505 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6403 | 0.070 |
Why?
|
Educational Measurement | 2 | 2012 | 1254 | 0.070 |
Why?
|
Torsades de Pointes | 1 | 2007 | 78 | 0.070 |
Why?
|
Physician Assistants | 1 | 2008 | 191 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3905 | 0.060 |
Why?
|
Collagen Type I | 1 | 2009 | 616 | 0.060 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 343 | 0.060 |
Why?
|
Intestinal Obstruction | 1 | 2009 | 432 | 0.060 |
Why?
|
Exanthema | 1 | 2010 | 503 | 0.060 |
Why?
|
Bone Diseases, Metabolic | 1 | 2009 | 409 | 0.060 |
Why?
|
Visual Perception | 1 | 2014 | 1387 | 0.060 |
Why?
|
Sleep | 4 | 2021 | 4768 | 0.060 |
Why?
|
Therapeutics | 1 | 2005 | 113 | 0.060 |
Why?
|
Focus Groups | 2 | 2024 | 1413 | 0.060 |
Why?
|
Motivation | 1 | 2015 | 2006 | 0.060 |
Why?
|
Sarcoidosis | 1 | 2010 | 521 | 0.060 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 527 | 0.060 |
Why?
|
Infertility, Female | 1 | 2010 | 760 | 0.060 |
Why?
|
Hospitalists | 1 | 2008 | 294 | 0.060 |
Why?
|
International Educational Exchange | 1 | 2004 | 49 | 0.060 |
Why?
|
Thrombosis | 1 | 2018 | 2942 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 823 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3358 | 0.060 |
Why?
|
Inpatients | 4 | 2019 | 2548 | 0.060 |
Why?
|
Lysosomes | 1 | 2009 | 924 | 0.060 |
Why?
|
Antigens | 1 | 2009 | 1443 | 0.050 |
Why?
|
Diarrhea | 1 | 2010 | 1318 | 0.050 |
Why?
|
Thromboembolism | 1 | 2010 | 995 | 0.050 |
Why?
|
Pyrimidines | 2 | 2007 | 3028 | 0.050 |
Why?
|
Models, Educational | 1 | 2006 | 373 | 0.050 |
Why?
|
Toxoplasmosis | 1 | 2003 | 94 | 0.050 |
Why?
|
Quality of Health Care | 4 | 2010 | 4330 | 0.050 |
Why?
|
Research Design | 1 | 2018 | 6180 | 0.050 |
Why?
|
Iatrogenic Disease | 1 | 2005 | 539 | 0.050 |
Why?
|
Medicine | 1 | 2010 | 942 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5440 | 0.050 |
Why?
|
Adult | 18 | 2018 | 221177 | 0.050 |
Why?
|
Risk Management | 1 | 2005 | 558 | 0.050 |
Why?
|
Anti-Infective Agents | 2 | 2014 | 983 | 0.050 |
Why?
|
Lung | 3 | 2018 | 10000 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2013 | 4544 | 0.050 |
Why?
|
Glycoproteins | 1 | 2009 | 2203 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5972 | 0.050 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1324 | 0.050 |
Why?
|
Sputum | 1 | 2003 | 506 | 0.050 |
Why?
|
Cardiomyopathies | 2 | 2010 | 1964 | 0.050 |
Why?
|
Dihydropteroate Synthase | 1 | 2000 | 27 | 0.050 |
Why?
|
Pneumocystis | 1 | 2000 | 55 | 0.050 |
Why?
|
Dapsone | 1 | 2000 | 56 | 0.040 |
Why?
|
Mycoses | 1 | 2003 | 386 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6770 | 0.040 |
Why?
|
HIV-1 | 2 | 2014 | 6863 | 0.040 |
Why?
|
Hematologic Tests | 2 | 2012 | 239 | 0.040 |
Why?
|
Immunity | 1 | 2006 | 996 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2010 | 1914 | 0.040 |
Why?
|
Mentors | 1 | 2004 | 661 | 0.040 |
Why?
|
Haiti | 1 | 2021 | 550 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 754 | 0.040 |
Why?
|
Fever of Unknown Origin | 1 | 1999 | 94 | 0.040 |
Why?
|
Retrospective Studies | 9 | 2022 | 80636 | 0.040 |
Why?
|
Faculty | 1 | 2021 | 384 | 0.040 |
Why?
|
Radiography | 4 | 2014 | 6965 | 0.040 |
Why?
|
Lymphatic Diseases | 2 | 2010 | 320 | 0.040 |
Why?
|
Peer Group | 1 | 2024 | 692 | 0.040 |
Why?
|
Biopsy | 4 | 2010 | 6766 | 0.040 |
Why?
|
Anti-Glomerular Basement Membrane Disease | 1 | 2018 | 41 | 0.040 |
Why?
|
Health Plan Implementation | 1 | 2021 | 337 | 0.040 |
Why?
|
Bacterial Infections | 1 | 2006 | 1390 | 0.040 |
Why?
|
Data Collection | 3 | 2015 | 3322 | 0.040 |
Why?
|
Tuberculosis | 1 | 2010 | 2017 | 0.040 |
Why?
|
Intensive Care Units | 3 | 2005 | 3745 | 0.040 |
Why?
|
Massachusetts | 2 | 2012 | 8830 | 0.040 |
Why?
|
Dementia | 1 | 2012 | 2686 | 0.040 |
Why?
|
Patient Discharge | 1 | 2010 | 3443 | 0.040 |
Why?
|
Myocardium | 1 | 2010 | 4726 | 0.040 |
Why?
|
Salvage Therapy | 1 | 2003 | 1264 | 0.040 |
Why?
|
Middle Aged | 17 | 2019 | 220895 | 0.030 |
Why?
|
Goals | 1 | 2012 | 711 | 0.030 |
Why?
|
Risk Factors | 5 | 2019 | 74206 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2018 | 755 | 0.030 |
Why?
|
Prednisone | 2 | 2010 | 1563 | 0.030 |
Why?
|
Length of Stay | 3 | 2019 | 6425 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 1995 | 5821 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11669 | 0.030 |
Why?
|
Dyspnea | 2 | 2014 | 1347 | 0.030 |
Why?
|
General Surgery | 1 | 2006 | 1692 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2024 | 1117 | 0.030 |
Why?
|
Models, Organizational | 1 | 2018 | 546 | 0.030 |
Why?
|
Actigraphy | 1 | 2019 | 520 | 0.030 |
Why?
|
Patient Readmission | 2 | 2019 | 3270 | 0.030 |
Why?
|
Bacteria | 1 | 2006 | 2199 | 0.030 |
Why?
|
Disasters | 1 | 2021 | 519 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1567 | 0.030 |
Why?
|
Protective Clothing | 1 | 2015 | 103 | 0.030 |
Why?
|
Liberia | 1 | 2015 | 174 | 0.030 |
Why?
|
Philadelphia | 1 | 2015 | 266 | 0.030 |
Why?
|
Attention | 1 | 2004 | 2396 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2395 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4320 | 0.030 |
Why?
|
Life Cycle Stages | 1 | 2014 | 160 | 0.030 |
Why?
|
Trypanocidal Agents | 1 | 2013 | 41 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 709 | 0.030 |
Why?
|
Sweating | 1 | 2014 | 155 | 0.030 |
Why?
|
Chloroquine | 1 | 2014 | 274 | 0.030 |
Why?
|
Arthritis, Psoriatic | 1 | 1996 | 219 | 0.030 |
Why?
|
Ciprofloxacin | 1 | 2015 | 312 | 0.030 |
Why?
|
Rocky Mountain Spotted Fever | 1 | 2012 | 19 | 0.030 |
Why?
|
New York City | 1 | 2015 | 731 | 0.030 |
Why?
|
Nitroimidazoles | 1 | 2013 | 117 | 0.030 |
Why?
|
Time Factors | 3 | 2019 | 39967 | 0.030 |
Why?
|
Arthritis, Infectious | 1 | 1996 | 347 | 0.030 |
Why?
|
Antibodies, Protozoan | 1 | 2013 | 252 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2010 | 6346 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2010 | 5368 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2850 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1386 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2009 | 5146 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2000 | 2199 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 369 | 0.020 |
Why?
|
Aged | 9 | 2019 | 169289 | 0.020 |
Why?
|
HIV Infections | 2 | 2014 | 17351 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1069 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2017 | 990 | 0.020 |
Why?
|
Endometritis | 1 | 2010 | 49 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8631 | 0.020 |
Why?
|
Hepatomegaly | 1 | 2010 | 84 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2004 | 7827 | 0.020 |
Why?
|
Polyuria | 1 | 2010 | 37 | 0.020 |
Why?
|
Learning | 1 | 2019 | 1740 | 0.020 |
Why?
|
Brain | 3 | 2012 | 27112 | 0.020 |
Why?
|
Gingival Hemorrhage | 1 | 2009 | 49 | 0.020 |
Why?
|
Hypergammaglobulinemia | 1 | 2009 | 71 | 0.020 |
Why?
|
Xerostomia | 1 | 2010 | 94 | 0.020 |
Why?
|
Diabetes Insipidus | 1 | 2010 | 144 | 0.020 |
Why?
|
Anorexia | 1 | 2010 | 154 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 397 | 0.020 |
Why?
|
Tryptases | 1 | 2010 | 176 | 0.020 |
Why?
|
Hypokalemia | 1 | 2010 | 153 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2013 | 697 | 0.020 |
Why?
|
Echocardiography | 2 | 2013 | 4989 | 0.020 |
Why?
|
Weight Loss | 2 | 2011 | 2684 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3233 | 0.020 |
Why?
|
Hydroxyurea | 1 | 2010 | 284 | 0.020 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 2008 | 114 | 0.020 |
Why?
|
Procollagen | 1 | 2009 | 187 | 0.020 |
Why?
|
Myasthenia Gravis | 1 | 2011 | 214 | 0.020 |
Why?
|
Toes | 1 | 2010 | 209 | 0.020 |
Why?
|
Critical Care | 1 | 2021 | 2696 | 0.020 |
Why?
|
Amiodarone | 1 | 2010 | 217 | 0.020 |
Why?
|
Electrocardiography | 2 | 2013 | 6377 | 0.020 |
Why?
|
Infarction | 1 | 2010 | 248 | 0.020 |
Why?
|
Atrioventricular Block | 1 | 2010 | 133 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2358 | 0.020 |
Why?
|
Granuloma | 1 | 2010 | 328 | 0.020 |
Why?
|
Urticaria | 1 | 2009 | 150 | 0.020 |
Why?
|
Angioedema | 1 | 2009 | 184 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1852 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4575 | 0.020 |
Why?
|
Jejunum | 1 | 2009 | 472 | 0.020 |
Why?
|
Cohort Studies | 1 | 2010 | 41487 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58976 | 0.020 |
Why?
|
Infertility, Male | 1 | 2010 | 395 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2901 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2010 | 534 | 0.020 |
Why?
|
Fingers | 1 | 2010 | 507 | 0.020 |
Why?
|
Patient Satisfaction | 2 | 2010 | 3461 | 0.020 |
Why?
|
RNA, Viral | 1 | 2015 | 2846 | 0.020 |
Why?
|
Travel | 1 | 2012 | 796 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 7407 | 0.020 |
Why?
|
Humeral Fractures | 1 | 2009 | 282 | 0.020 |
Why?
|
Inflammation | 1 | 2006 | 10773 | 0.020 |
Why?
|
Skin | 2 | 2010 | 4484 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 3023 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20570 | 0.020 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2010 | 774 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1081 | 0.020 |
Why?
|
Endocarditis | 1 | 2010 | 348 | 0.020 |
Why?
|
Medical History Taking | 1 | 2009 | 774 | 0.020 |
Why?
|
New England | 1 | 2008 | 1054 | 0.020 |
Why?
|
Malaria | 1 | 2015 | 1227 | 0.020 |
Why?
|
Anthracyclines | 1 | 2007 | 284 | 0.020 |
Why?
|
Molecular Structure | 1 | 2009 | 1880 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2007 | 1379 | 0.010 |
Why?
|
Hypothyroidism | 1 | 2009 | 668 | 0.010 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2010 | 628 | 0.010 |
Why?
|
Fatigue | 1 | 2011 | 1552 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2013 | 1490 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2010 | 1086 | 0.010 |
Why?
|
Drug Resistance, Fungal | 1 | 2003 | 75 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2015 | 3156 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1738 | 0.010 |
Why?
|
Mast Cells | 1 | 2010 | 1392 | 0.010 |
Why?
|
Amino Acids | 1 | 2009 | 1718 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8529 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1755 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21012 | 0.010 |
Why?
|
Fertilization in Vitro | 1 | 2010 | 1292 | 0.010 |
Why?
|
Vision Disorders | 1 | 2010 | 1088 | 0.010 |
Why?
|
Oxygen | 1 | 2014 | 4227 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3810 | 0.010 |
Why?
|
Colon | 1 | 2010 | 1792 | 0.010 |
Why?
|
Transplantation | 1 | 2003 | 219 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8465 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2915 | 0.010 |
Why?
|
Antitubercular Agents | 1 | 2010 | 1375 | 0.010 |
Why?
|
Attitude | 1 | 2006 | 775 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2010 | 2010 | 0.010 |
Why?
|
Prospective Studies | 3 | 2017 | 54425 | 0.010 |
Why?
|
Disease Progression | 2 | 2015 | 13506 | 0.010 |
Why?
|
Mutation | 2 | 2009 | 30052 | 0.010 |
Why?
|
Ischemia | 1 | 2010 | 1882 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6228 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10552 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2161 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6310 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2911 | 0.010 |
Why?
|
Stroke Volume | 1 | 2013 | 5496 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6534 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2010 | 2557 | 0.010 |
Why?
|
Medication Errors | 1 | 2005 | 783 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5492 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 4021 | 0.010 |
Why?
|
Fibroblasts | 1 | 2009 | 4141 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12059 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2010 | 3466 | 0.010 |
Why?
|
Testosterone | 1 | 2009 | 2472 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23995 | 0.010 |
Why?
|
Polysomnography | 1 | 2004 | 1848 | 0.010 |
Why?
|
Sulfones | 1 | 2000 | 448 | 0.010 |
Why?
|
Treatment Failure | 1 | 2003 | 2645 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2009 | 13446 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13255 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6485 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17635 | 0.010 |
Why?
|
HIV | 1 | 2003 | 1582 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2693 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15601 | 0.010 |
Why?
|
Liver | 1 | 2010 | 7529 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21353 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64680 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 36426 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26125 | 0.010 |
Why?
|
Hospitalization | 1 | 2012 | 10723 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2003 | 1896 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10194 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20098 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2007 | 3613 | 0.010 |
Why?
|
Prognosis | 1 | 2011 | 29625 | 0.010 |
Why?
|
Asthma | 1 | 2009 | 6234 | 0.010 |
Why?
|
Hand | 1 | 1996 | 902 | 0.010 |
Why?
|
Survival Analysis | 1 | 2003 | 10090 | 0.010 |
Why?
|
Hypertension | 1 | 2009 | 8540 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13639 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39106 | 0.000 |
Why?
|
Chronic Disease | 1 | 1996 | 9318 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2003 | 15631 | 0.000 |
Why?
|
Adolescent | 1 | 2008 | 88319 | 0.000 |
Why?
|
Animals | 1 | 2009 | 168459 | 0.000 |
Why?
|
Child | 1 | 2003 | 80153 | 0.000 |
Why?
|
Neoplasms | 1 | 2003 | 22170 | 0.000 |
Why?
|